
Prof.
Ivan Kopitović, MD, PhD
SpecializationInternal Medicine
SubpecializationPulmonology
Head of the Service
Phone021/4805100
Prof. Dr. Sci. Med. Ivan Kopitović is a specialist in internal medicine and a subspecialist in pulmonology, a full professor at the Faculty of Medicine, University of Novi Sad, and a physician at the Institute for Lung Diseases of Vojvodina. He is the head of the Service for Pathophysiology of Breathing and Sleep-Related Respiratory Disorders. He is engaged in clinical and research work in the field of chronic obstructive pulmonary disease, asthma, asthma-COPD overlap syndrome, sleep-related breathing disorders, and respiratory physiology.
Teaching engagement
Faculty of Medicine, University of Novi Sad
Department of Internal Medicine
| Field | Year of completion | Degree | Faculty | |
|---|---|---|---|---|
| Doctor of Medicine | 1995 | Faculty of Medicine Novi Sad | ||
| Master of Science | 2001 | Faculty of Medicine Novi Sad | ||
| Specialist in Internal Medicine | 2002 | Faculty of Medicine Novi Sad | ||
| Subspecialist in Pulmonology | 2010 | Faculty of Medicine Novi Sad |
| Training name | Field | Year | Organizer |
|---|---|---|---|
| Visiting Clinician Program | 2011 | Mayo Clinic, USA | |
| EAACI Beijing Allergy School | 2026 | China |
| Period | Title | Project role |
|---|---|---|
| Serbian COPD Position Statement | member of the working group / co-author | |
| SmokeFreeBrain | IPBV – partner | |
| International Delphi Study on Respiratory Oscillometry | expert/participant |
European Respiratory Society (ERS)
European Sleep Research Society (ESRS)
American Thoracic Society (ATS)
Serbian Medical Society
Kopitović I, et al. The Prevalence of Emphysema in Patients Undergoing Lung Cancer Screening in a Middle-Income Country. Diseases, 2025.
Valipour A, Kopitović I, et al. Recommendations for COPD Management in Central and Eastern Europe. Expert Rev Respir Med, 2022.
Ilić M, Kopitović I, et al. Home-Based Spirometry in Interstitial Lung Diseases: A Real-Life Pilot Study. J Pers Med, 2023.